myAMDteam

Are you asking about the new light therapy device for dry AMD?

The FDA recently authorized the Valeda Light Delivery System, which is the first treatment that may actively improve vision in people with dry AMD. This device uses photobiomodulation therapy - a technology that uses light at three specific wavelengths to improve Show Full Answer

Are you asking about the new light therapy device for dry AMD?

The FDA recently authorized the Valeda Light Delivery System, which is the first treatment that may actively improve vision in people with dry AMD. This device uses photobiomodulation therapy - a technology that uses light at three specific wavelengths to improve retinal health, reduce inflammation, and enhance visual clarity.

Treatment is administered by eye care professionals in their office. Each session lasts about four minutes per eye. A typical course involves nine sessions total - usually three sessions per week for three to four weeks.

In clinical trials, people who received Valeda treatment saw significant vision improvement and preservation lasting up to 24 months, especially for those in early or intermediate stages of AMD. The treatment also helped reduce the number of people who progressed to severe geographic atrophy. No significant side effects were reported.

Importantly, the therapy works best for people with intermediate dry AMD. Those with more advanced stages like central geographic atrophy or wet AMD may not experience the same benefits.

If you're interested in this treatment, talk to your ophthalmologist about whether it might be right for you.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Vision-Saving Device for Dry AMD Lands FDA Authorization

5 Treatments for AMD: Injections, Laser Therapy, and New Approaches